Cryo Cell International (CCEL) Capital Expenditures (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Capital Expenditures data on file, last reported at $67065.0 in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $67065.0, up 8.08% year-over-year; the trailing twelve-month figure through Feb 2026 was $235487.0 (down 88.27% YoY), and the FY2025 annual result was $230475.0, down 90.41% from the prior year.
• Capital Expenditures steadied at $67065.0 in Q1 2026 per CCEL's latest filing, from $67226.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $11.2 million in Q3 2022 and troughed at -$25011.0 in Q4 2022.
• A 5-year average of $1.3 million and a median of $306970.0 in 2022 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures slumped 108.93% in 2022, then jumped 6956.64% in 2023.
• A 5-year view of Capital Expenditures shows it stood at -$25011.0 in 2022, then jumped by 6956.64% to $1.7 million in 2023, then slumped by 99.51% to $8348.0 in 2024, then surged by 705.29% to $67226.0 in 2025, then retreated by 0.24% to $67065.0 in 2026.
• Business Quant data shows CCEL's Capital Expenditures at $67065.0 in Q1 2026, $67226.0 in Q4 2025, and $38788.0 in Q3 2025.